Dr. Harold C. Smith Fund of Ursinus College Official Prospectus, May 2, 2017 by Myers, Johnathan et al.
Ursinus College
Digital Commons @ Ursinus College
Ursinus Student-Managed Investment Fund
Prospectus Ursinus College Student Managed Investment Fund
5-2-2017
Dr. Harold C. Smith Fund of Ursinus College











See next page for additional authors
Follow this and additional works at: https://digitalcommons.ursinus.edu/smith_fund_prospectus
Part of the Finance and Financial Management Commons, and the Portfolio and Security
Analysis Commons
Click here to let us know how access to this document benefits you.
This Prospectus is brought to you for free and open access by the Ursinus College Student Managed Investment Fund at Digital Commons @ Ursinus
College. It has been accepted for inclusion in Ursinus Student-Managed Investment Fund Prospectus by an authorized administrator of Digital
Commons @ Ursinus College. For more information, please contact aprock@ursinus.edu.
Recommended Citation
Myers, Johnathan; Klybor, Benjamin R.; Abrams, Isaac; Slaats, Daan; Wolf, Parker; Sjosten, Sam; and Deacle, Scott, "Dr. Harold C.
Smith Fund of Ursinus College Official Prospectus, May 2, 2017" (2017). Ursinus Student-Managed Investment Fund Prospectus. 1.
https://digitalcommons.ursinus.edu/smith_fund_prospectus/1
Authors
Johnathan Myers, Benjamin R. Klybor, Isaac Abrams, Daan Slaats, Parker Wolf, Sam Sjosten, and Scott Deacle





The Rev. Dr. Harold C. Smith Fund 
of Ursinus College 
 
Managed by the student members and faculty of the Ursinus College Investment Club 
 
Official Prospectus 
May 2, 2017 
 
Johnathan Myers  /  President 
Benjamin Klybor  /  Vice President 
Isaac Abrams  /  Secretary 
Daan Slaats  /  Treasurer 
Parker Wolf, Sam Sjosten  /  Public Relations Officers 













Table of Contents 
History and Mission of the Student Managed Investment Fund...………………………………… 3 
Governing Principles and Investment Strategy.…………………………………………………… 4 
Thesis for Enanta Pharmaceuticals (NYSE: ENTA)...…………………………………………….. 7 
Thesis for Garmin Ltd. (NYSE: GRM) …………………………..………………………………. 9 
Thesis for Pioneer Natural Resources (NYSE: PXD) ………………………..………………... …10 








History and Mission of the Rev. Dr. Harold C. Smith Fund 
The Ursinus College Investment Club was founded in 2003 by Ursinus student Daniel Uba, 
who currently works in the investment industry as a supervisor at Vanguard. From 2007 to 2011, the 
club was defunct, partly due to turnover in the faculty adviser position. It was resurrected in 2011 by 
Dr. Andrew Economopoulos and student Matt Yuros. During this time, Dr. Scott Deacle became 
the club adviser. The club became defunct again in Fall 2015, but students Anthony Chang and 
Johnathan Myers changed the image of the Investment Club in Spring 2016. They raised funds for a 
student-managed investment fund and took the club from simulations, discussion, and work-
shopping to the management the Rev. Dr. Harold Smith Fund, a $12,500 portfolio managed on 
behalf of the college.   
The Smith Fund was named after its initial donor, the Rev. Dr. Harold Smith, a member of 
the Ursinus class of ’55 as well as an investment manager, ordained minister, and member of the 
Ursinus Board of Trustees. Dr. Smith believed that practical experience researching and investing 
stock would be a valuable component of students’ training in finance and economics. The work and 
learning that the Ursinus College Investment Club does today would not be possible without his 
support.  
Student analysts working on the Smith Fund strive to be value investors, looking for 
companies whose valuation is not currently reflected in market prices. They search for firms with 
low and serviceable debt, reasonably high levels of cash, realistic possibilities for rapid growth, and a 
commitment to innovation and change. The investment club’s long-term goal is to create a strong 
and lasting portfolio, and we seek to achieve steady and long-term growth.  
 The Ursinus College Investment Club prides itself on full participation of all members, 
efficient bureaucracy, and a dedicated passion for learning. In line with Dr. Smith’s advice, education 
about stocks, the market, and the economy remains its top priority. While generating a healthy 
portfolio is an ambitious goal, our club values parallels the mission of Ursinus to enable students to 





Governing Principles and Investment Strategy  
The Ursinus Investment Club’s mission is to help students learn and understand the 
complexity of financial markets, securities, and institutions; to develop skills in economic, industry 
and security analysis; and to effectively communicate our understanding of investing strategies and 
fundamentals to others. We aim to develop a deep and thorough understanding of investment 
strategies, complete thorough research on companies, and make informed and thesis-driven 
decisions that will help grow the portfolio. The Ursinus College Investment Club is solely 
responsible for the Smith Fund, is a $12,500 portfolio owned by the college. Participating in the 
Smith Fund entails the following: conducting independent research on stocks, evaluating market 
trends presenting findings in a group setting, using online research tools, answering questions about 
findings, conducting follow-up research, and working closely with the Executive Committee and 
various Faculty to make informed investing decisions. 
 
Smith Fund participants are organized into three levels of membership: the Executive 
Committee, Analyst Directors, Analysts, and General Members. The Executive Committee consists 
of the Club President, Vice President, Secretary, and Faculty Advisor. The Executive Committee 
organizes meetings, approves final decisions, collaborates with analysts to develop stock picks, 
reaches out to potential new members, participates in club meetings, and communicates orders to 
the Ursinus business office. The Analyst Directors consist of the investment club’s President, Vice-
President, and Secretary. The Analyst Directors educate new analysts on how to conduct research 
and provide leadership. Analysts and Analyst Directors conduct research on stock selections, present 
findings to the Investment Club, and decide which stocks to use in the final portfolio. 
 
Analysts and Analyst Directors make presentations on their research to the entire team. 
Investment decisions are made once a variety of investment options have been presented by analysts 
and a consensus has been reached on attractive bets. Investment decisions are not made without 
some written analysis.  Consensus of the Executive Committee members is required before all 
security transactions. Once the investments in the portfolio are secured, the Investment Club will 
meet weekly to review the performance of the portfolio.  A special meeting of the Investment Club 
can be called by the Faculty Advisor, or by any member of the Analyst Directors with the approval 
of a Faculty Advisor. 
 
 The Smith Fund selected purchased its first four stocks on April 7, 2017. Smith Fund 
analysts found what they believe to be undervalued stocks through a number of avenues. The 
primary strategy was to find stocks with low price-to-earnings ratios relative to appropriate 
benchmarks, including sector and industry price-to-earnings ratios. Within those subsets, analysts 
identified companies with strong balance sheets based on their debt-to-assets, current, and quick 
ratios. Analysts then searched for companies with the potential for rapid earnings growth in the next 
two to three years if one or two changes that have a reasonable chance of occurring in fact occur. As 
the below pie chart shows, the club invested roughly equal amounts of about $2,500 in each stock. 





The four stocks that were selected are Enanta Pharmaceuticals (ENTA), Garmin Ltd. 
(GRM), Pioneer Natural Resources (PXD), and WalMart Stores, Inc. (WMT). A brief report on each 
stock and the rationale for its selection follows this section. This report will go to our donors, 
Ursinus college CFO Annette Parker and others in the college’s business office, alumni advisers, and 
the college board of trustees’ endowment committee.  
 
Sell Strategy 
 Our sell strategy is not contingent on stock price but on how well our thesis for each 
company holds over time. We are not looking for a specific threshold to trigger a sell, but we will be 
wary of a rapid increase in stock price from any company. We are continually monitoring news 
sources to check any change in corporate information. We use historical data to predict the valuation 
of a company in the future. We are constantly forward-looking in our evaluations and know it’s 
penny-wise, dollar-foolish to sell a great company. In the case of damaging events, we are willing to 
sell our shares of a stock. For example, Enanta is a company that has high risk and the potential for 
negative returns if their pipeline drug is not passed. If this happens, we will examine our news 
sources, shareholder information, and historical evidence to arrive at a decision.  
Summer Procedures 
During the summer vacation, we will monitor stock price fluctuations and regularly re-
evaluating our portfolio using our sell strategy. UCIC members will conduct news-based research on 
companies in the portfolio using online news sources and alert the other members of the Investment 




order to stay alert and productive over the summer. One shift over the summer will be responsible 
for the market as a whole, briefly evaluating trends and conducting basic research to report to the 
other members of the club in a summary. Through this method, we are able to keep researching our 





Thesis for Enanta 
Enanta Pharmaceuticals     Industry: Biotechnology 
NYSE: ENTA      Market Cap: $580m 
Headquarters: Watertown, MA    Share Price at Purchase: 29.70 
Summary: Enanta Pharmaceuticals has several drugs in development which, if approved by 
the FDA, would see the company to sustained growth over the foreseeable future. While Enanta is 
in a volatile industry, we believe that it represents a safe selection due to its stream of royalties from 
its work with AbbVie, its expansion into the potentially lucrative non-alcoholic steatohepatitis 
(NASH) treatment market, and its continuing self-investment. 
Thesis: Enanta has developed, brought to market, and is collecting royalties from a major 
component, called paritaprevir, in AbbVie’s Hepatitis C virus (HCV) treatment, which is called 
Viekira Pak. The Viekira Pak was AbbVie’s 3rd highest grossing product in 2016. Enanta currently 
has a follow-up component in development and is expanding into the treatment of liver and viral 
diseases as well. Through their partnership with AbbVie, Enanta has successfully brought its 
component ingredient for the treatment of HCV to market. While Enanta has a strong balance 
sheet, this investment is partially a gamble, and its success is contingent on the FDA approval of two 
of the company’s newest drugs; namely glecaprevir, as an additional component to AbbVie’s HCV 
treatment, and EDP-305, for the treatment of NASH. Enanta’s potential for quick and sustained 
growth with the change of a few factors fits perfectly in the Investment Club’s thesis for a successful 
company. 
Background: In addition to HCV, Enanta is currently focused on treatments for four other 
diseases: NASH, primary biliary cholangitis (PBC), respiratory syncytial virus (RSV), and hepatitis B 
virus (HBV). NASH affects over 3 million Americans each year, PBC affects about 200,000 
Americans, RSV may affect about 1-2% of the U.S. infant population, and HBV affects more than 
200,000 Americans each year. Enanta’s ability to find cures or effective treatments for these diseases 
will determine its ability to generate rapid earnings growth. Enanta’s research so far has led to 
breakthroughs in treating Hepatitis C, and it is also developing early lead candidates for cures for 
HBV.  
Financials: The company’s financials show a strong balance sheet very strong cash. Its cash 
and cash equivalents grow consistently over the past five years, with its current ratio and quick ratio 
almost tripling from 11.68 to 29.43 and 10.98 to 28.26 respectively. Since Enanta saw losses last 
quarter, its P/E ratio is now negative (-62.50). Over the past five years, however, it has been 
consistently undervalued compared to its industry as its P/E ratio has averaged 14.22 compared to 
the industry average of 24. Although the company is currently losing money, it has more than 
enough liquid assets to cushion the present downturn. In addition, Enanta has been and remains 
free. Since its initial public offering, it has only paid interest on debt for one year.  
Growth, Market Analysis and Risk: Many things could dent Enanta’s share price over the 




even though the FDA has given it priority review; the firm’s expansion into the Japanese market 
could be stifled by tariff barriers; and the market for its NASH drug could end up being smaller than 
anticipated. Many of these risks are, however, independent of each other. In other words, for Enanta 
to perform significantly worse than we anticipate, many uncorrelated things would have to go 
wrong. We believe that Enanta has the potential for massive growth in the future with minimal risk 
because of their work with AbbVie, its expansion into the treatment market, and its continued 




Thesis for Garmin 
Garmin Ltd.       Industry: Technology 
NYSE: GRMN      Market Cap: $9,413m 
Headquarters: Schaffhausen, Switzerland   Share Price at Purchase: $50.43 
 Summary: We believe that Garmin is a smart choice, since the company is already 
recognized as a leading worldwide provider of GPS technology and additionally successfully 
launched its new wearable product.  It should therefore await a steady growth in the foreseeable 
future. 
Thesis: Garmin’s GPS based products are supplied to a broad range of industries. 
Therefore its resources are spread across various markets as the company does not specifically focus 
in any particular area. Garmin’s recent successful entrance into the wearables industry shows how 
the company has been able to adapt and innovate its technology in order to fulfill the consumer’s 
needs. In order for the company to endure in its operating industries it will need to continue to 
adapt.  
Background: Garmin is a provider of consumer and commercial electronics.. It designs and 
manufactures multiple GPS based devices for various markets. Its five business segments include 
automotive, marine, aviation, outdoor and sports. The company’s vision is to be the global leader in 
every market they serve, with their products being sought after for their compelling design, superior 
quality and best value. It hopes to be an enduring company by creating superior products that play 
an essential part in the customers’ lives.  
Financials: Garmin’s financials appear fairly similar to the average in its industry. It is a 
financially stable company with a low P/E ratio of 18.91 (Industry average: 26.02) and a low Debt-
to-Equity ratio of .28 (Industry average: 1.06. At the moment it has a quick ratio of 2.27 (Industry 
average: 3.76) and a high Interest Coverage Ratio of 126.54 (Industry average: 9.22). Furthermore, 
between 2015 and 2016 the sales in Garmin’s wearable increased by 324%.  
 Growth, Market Analysis and Risk: Garmin’s growth will depend on its ability to 
continue to adapt to the consumer’s needs. It has increased its spending in R&D, which should 
hopefully pay off in the long run to create flourishing products. Garmin has done well with its 
release of its wearable to compensate for the declining automotive personal navigation device 
(PND) market. There still may be some risk though, since the company has been relatively 
dependent on PND, but its revenue in the automotive segment has been declining in the past years 
due to less demand. However, we expect that Garmin will continue to grow steadily in the booming 
wearable market, mainly competing against Apple’s and FitBit’s similar wearable device. It may 
outcompete these companies and come out as a leader in this market.     





Thesis for Pioneer Natural Resources 
Pioneer Natural Resources     Industry: Natural Resources 
NYSE: PXD       Market Cap: $29,645m 
Headquarters: Irving, TX     Share Price at Purchase: $191.40 
 Summary: Pioneer Natural Resources extracts oil primarily from low-risk shale fields in the 
United States. Though in a temporary downturn, Pioneer is in the oil and natural sector, which we 
believe will rebound in the next two to five years.  
Thesis: Pioneer has a clear and visible path to earnings growth for the next decade through 
its Texas-based oil producing structure. Growing sales, effective use of technology, and smart 
selection of oil drilling prospects has generated growth in re-investment that we and other analysts 
to expect produce rapid growth in cash flow. Pioneer management has laid out an operational goal 
of 15%+ annual total production growth through the year 2026. They have been reducing costs and 
operating more efficiently through a vertically integrated system that we expect to perform better 
than the 12.5% service cost inflation experienced in the oil industry throughout this year. 
Maintaining a strong balance sheet is a top priority for the firm as it continues to expand through 
the oil industry. We believe that it has high potential in a strong market. 
Background: Pioneer was developed through a merger in 1997 of two companies that were 
built through acquiring and exploiting oil fields. Along with production throughout North America, 
Pioneer Natural Resources also operates internationally. The company has consistently found low-
risk sites to operate on. Recently, in 2013, Pioneer Natural Resources successfully merged with 
Pioneer Southwest Energy Partners L.P., strengthening its financials in the process. 
Financials: Pioneer is strong in short-term assets, shown in its 1.96 quick ratio as well as its 
2.11 current ratio, 0.31 total-debt-to-equity ratio. Along with that, the Enterprise Value is 41.93, the 
EPS trend this quarter is .16, and the current year’s expectation is 1.84, with next year’s being 4.36. 
EPS last year at this time was -.64, and last quarter it was .49. It has astounding growth estimates.  
Growth, Market Analysis and Risk: Overall, Pioneer Natural Resource is showing us a 
low-risk opportunity with high potential within the Gas and Natural Resource sector. The market 
that PXD flows throughout is stable and can provide support even if the company underperforms.  
It can finance its 15% compound production growth within cash starting next year if oil and natural 
gas prices are at least $55 and $3, respectively. Only 15 companies have matched Pioneers growth 
rate and projected growth rate in the past several years, and most of those companies are technology 
sector giants. We believe that it has great estimated potential to outperform the market for the next 





Thesis for WalMart 
WalMart Stores, inc.      Industry: Multinational Retail 
NYSE: WMT       Market Cap: $229,853m 
Headquarters: Bentonville, AR    Share Price at Purchase: 74.80 
Summary: The acquisitions of smaller companies, growth into developing countries, and 
competitive online services make WalMart a stock that promises steady and growing returns. 
Thesis: WalMart is the United State’s largest company by revenue, with fiscal year 2016 
revenue of $482.1 billion. WalMart has managed to maintain domination in the market by 
purchasing a number of smaller retail companies, including ModCloth and Moosejaw. WalMart has 
developments in the United States as well as internationally, focusing on markets in Mexico, Chile, 
other South American countries, and many European countries. WalMart is a company that 
promises steady growth through the acquisition of smaller companies, the competitive growth of 
online retail, and the expansion into developing countries.  
 
Background: WalMart was founded in 1962 by Sam Walton, who had opened a number of 
“Five and Dime” business models that operated on low profit margins but high volume sales. 
WalMart’s business model has stayed consistent with the founding principles, and its economic 
influence has spread across the globe. By 1990, WalMart became the largest retailer by revenue in 
the United States. WalMart has historically taken advantage of modern economies, from being the 
nation’s leader in using solar panels to its acquisition of jet.com and competition in online retail. 
WalMart’s ability to adapt to current trends and acquire smaller companies makes it one of the most 
competitive and influential companies in the world. 
 
Financials: WalMart’s ratios and numbers show steady growth and initiative. Currently, 
WalMart is an undervalued stock: its P/E ratio is 15.33, which is nearly half of the service sector of 
the economy's P/E ratio of 33.00, and discount variety stores’ 21.70. WalMart’s 2016 current ratio is 
0.93, which shows marginal growth since 2010 with a 0.87 current ratio. WalMart’s interest coverage 
is 9.77 as of 2016, which demonstrates that WalMart has functioning liquid capital and can cover its 
debts quickly. WalMart’s debt to equity ratio of 0.62 shows that WalMart’s combined long-term and 
short-term debts are unlikely to overwhelm the company if it hits a rough patch. WalMart's dividend 
yield is 2.78%, which is the second-highest compared to big box stores such as Costco, Dollar 
General, and PriceSmart. WalMart’s dividend yield has steadily increased over the past few years, 
which suggests that WalMart is a safe, stable, and secure company. 
  
Growth, Market Analysis, and Risk: WalMart is the owner of many companies that 
operate in wholesale and online retail. Sam’s Club, founded in 2012, captures a higher-income 
demographic with a membership fee and operates the same business model as WalMart. WalMart 
purchased Asda, a British supermarket retailer, in 1999. In August of 2016, WalMart announced the 
plan to acquire Jet.com, an online retailer in competition with Amazon, for $3.3 billion, and 




clothing companies: ModCloth and MooseJaw. WalMart’s continuous growth in wholesale business 
models demonstrate their omnipresence and steady growth. 
  
WalMart’s entry into online retail, like most of its business operations, is cutthroat 
competitive. WalMart unveiled free 2-day shipping online in late January 2017, competing with 
Amazon Prime’s 2-day shipping for $35/yr. In an interview, the CEO of WalMart US eCommerce 
said, “We are moving at the speed of a startup. Two-day free shipping is the first of many moves we 
will be making to enhance the customer experience and accelerate growth.” 
  
WalMart has made serious international expansion, with lofty and ambitious goals of 
expanding into the international market. While the United States is the home of WalMart, the 
company has serious roots in England, Canada, and Mexico, and has been looking in Chile. Asda, 
England’s third largest grocery store and WalMart’s subsidiary, generated a revenue of $33 billion 
last fiscal year, and had an operating income of over $1 billion. WalMart Mexico has a revenue of 







Performance (as of 5/1/17) 













Since Purchase to 
5/1/2017 (%)  
ENTA 84 29.70 2,494.94 32.13 2,698.92 8.81 
GRMN 50 50.43 2,521.50 51.83 2,591.50 2.78 
PXD 13 191.40 2,488.20 172.43 2,241.59 -9.91 
WMT 34 72.37 2,460.41 75.23 2,557.82 3.96 
Portfolio n/a n/a 9,965.04 n/a 10,089.83 0.97 
 
From the initial purchases on April 7, 2017 until the writing of this report on May 1, 2017, 
the portfolio is up 0.97% (for comparison the S&P500 is up 1.36%, DJI is up 1.21%, and the 
NASDAQ is up 3.62% over the same time period). While Pioneer is down 9.91%, responsible for 
the fund’s short-term underperformance, the current loss is within our tolerance for keeping it in the 
portfolio. Pioneer’s negative contribution to the fund is expected at this time as the company 
continues to lessen its relatively small debt burden. As explained above, our main reason for adding 
Pioneer to the portfolio is its low debt burden when compared to the rest of the oil industry. More 
cheerily, we see positive returns in the rest of the portfolio. Enanta’s performance (up 8.18%) 
continues to support our analysis that it is a long-term valuable company, not likely to fade away or 
disappoint any time soon. As evidence, Enanta recently reported high sustained viral response rates 
in an eight-week trial treatment with AbbVie’s forthcoming genotype-3 HCV treatment, for which 
Enanta has created a key component. Looking to Walmart (up 3.96%) we see that company’s 
continuing campaign to increase its online and technology presence, parts of its business that will 
only continue to grow in coming years. As evidence Walmart recently announced the initiation of a 
start-up-like division called “Store No.8” that will be dedicated to seeking out and developing new 
technologies and innovations to support the company’s e-commerce division as well as its 
traditional, megastore division. Finally, on to Garmin (up 2.78%), where we see the tech company’s 




Garmin continues to increase its presence in everything from mobile applications and military 
hardware to medical monitoring and high-quality retail watches, we expect to keep Garmin for its 
long-run value and let the return generate speak for itself. As the pie chart below shows, the each of 
the four stocks still occupies a roughly equal share of the portfolio. 
 
While the fund has only been in existent for these short three weeks, all of us here at the 
fund are proud of what we have achieved so far and are excited about what we plan to achieve in the 
future. 
